(1) reduktion af hepatisk glukoseproduktion ved at hæmme gluconeogenese og glycogenolyse (2) i muskler, ved øgning af følsomheden over for insulin, forbedring af perifer glukoseoptagelse og udnyttelse (3) og forsinkelse af intestinal glukoseabsorption.
(1) reduction of hepatic glucose production by inhibiting gluconeogenesis and glycogenolysis (2) in muscle, by increasing insulin sensitivity, improving peripheral glucose uptake and utilisation (3) and delay of intestinal glucose absorption.